What does Inbrija treat?: A Guide to Inhaled Levodopa for Parkinson's
•
4 min read
Approved by the FDA in 2018, Inbrija is the first inhaled levodopa therapy designed to treat "OFF" episodes in people with Parkinson's disease who are already on a carbidopa/levodopa regimen. This on-demand medication helps to rapidly alleviate the return of motor symptoms experienced between regular doses.
